IXICO (LSE:IXI) Ending Cash Position : £2.53 Mil (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is IXICO Ending Cash Position?

IXICO's Ending Cash Position for the quarter that ended in Mar. 2024 was £2.53 Mil.

IXICO's quarterly Ending Cash Position declined from Mar. 2023 (£5.02 Mil) to Sep. 2023 (£4.03 Mil) and declined from Sep. 2023 (£4.03 Mil) to Mar. 2024 (£2.53 Mil).

IXICO's annual Ending Cash Position declined from Sep. 2021 (£6.68 Mil) to Sep. 2022 (£5.77 Mil) and declined from Sep. 2022 (£5.77 Mil) to Sep. 2023 (£4.03 Mil).

IXICO Ending Cash Position Historical Data

The historical data trend for IXICO's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IXICO Ending Cash Position Chart

IXICO Annual Data

Trend

Sep13

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Ending Cash Position

Get a 7-Day Free Trial

7.26

7.95

6.68

5.77

4.03

IXICO Semi-Annual Data
	Mar14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															5.80	5.77	5.02	4.03	2.53

IXICO Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

IXICO's Ending Cash Position for the fiscal year that ended in Sep. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	5.769	+	-1.738
	=	4.03

IXICO's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4.031	+	-1.499
	=	2.53

IXICO Ending Cash Position Related Terms

Thank you for viewing the detailed overview of IXICO's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

IXICO (LSE:IXI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IXICO PLC (LSE:IXI) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

PHYOF:USA

Address

15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN

Website

https://www.ixico.com

IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.

IXICO (LSE:IXI) Headlines

No Headlines